logologo
QuantliQuantli

Z Squared Inc (Delaware)

ZSQR

NASDAQ

Biotechnology

$3.94

USD

-0.22 (-5.29%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $219.83M

Volume 248.9K

Price (USD)
Price (USD)

About Z Squared Inc (Delaware)

Z Squared, Inc. is a vertically integrated computing infrastructure company operating advanced computing equipment strategically distributed across North Carolina, South Carolina, and Iowa. The company is headquartered in Wexford, Pennsylvania and currently employs 4 full-time employees. The company went IPO on 2020-12-17. The firm's operations include crypto mining, which provides a foundation for its verticals in power generation, data center development, and high-performance compute hosting. The firm manages and optimizes a fleet of specialized computing hardware, supported by power management strategies, real-time analytics dashboards, and a comprehensive in-house repair and life cycle management program. The firm's infrastructure supports agile redeployment of equipment based on shifting power costs, infrastructure readiness, and uptime performance. The firm is focused on responding to real-time grid conditions, including curtailment schedules and seasonal electricity rate fluctuations.

CEO

Mr. David Mehalick

HQ

Wexford, PENNSYLVANIA, US

Founded

2020

Employees

4

Key Statistics

Open

$4.02

Previous Close

$4.16

Day Range

$3.85 - $4.15

52 Week Range

$3.77 - $18.80

Volume

248.9K

Average Volume (10 Days)

380.0K

Dividend Yield

Valuation Measurement

Market Cap

$219.83M

P/E Ratio (TTM)

Turn research into action

Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.

Position Strategy

Ride market cycles. Patient hold.

Best for:

Patient investors

Swing Strategy

Buy support, sell on recovery.

Best for:

Risk-tolerant

Trend Following

Enter on trend. Cut losses fast.

Best for:

Active traders

Go deeper on ZSQR

Similar Stocks

AVXL

Anavex Life Sciences Corp

$3.22

-1.5%

ANIK

Anika Therapeutics Inc

$21.50

+1.6%

SRZN

Surrozen Inc

$23.96

+1.0%

MYGN

Myriad Genetics Inc

$3.03

-4.4%

RNAC

Cartesian Therapeutics Inc

$8.84

+1.4%

TRDA

Entrada Therapeutics Inc

$7.46

+0.1%

ALXO

ALX Oncology Holdings Inc

$1.96

+1.0%

ELDN

Eledon Pharmaceuticals Inc

$3.54

-4.3%

Earnings Calendar

Next Earnings

Estimated Q3 Release

Nov 11